OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on July 1, 2016. The report addresses Item 8.01 (Other Events) regarding the status of the Company's 3.0% Convertible Senior Notes due 2033.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. Specific financial details disclosed include:
- Outstanding Debt: $32.2 million in 3.0% Convertible Senior Notes due 2033.
- Stock Price Threshold: The closing price per share exceeded $9.19 (130% of the conversion price of $7.07) for at least 20 of 30 consecutive trading days during the quarter ended June 30, 2016.
- Conversion Rate: 141.4827 shares of common stock per $1,000 principal amount of Notes, plus applicable additional shares under early conversion provisions.
Material Changes
The primary material change is the confirmation that the conversion right for the Notes has been extended through September 30, 2016. This extension follows the same trigger conditions met in the quarters ended March 31, 2015, June 30, 2015, September 30, 2015, December 31, 2015, and March 31, 2016. The Company has elected to satisfy any conversion obligations in shares of common stock.
Outlook, Risks, and Management Commentary
The Notes will remain convertible until September 30, 2016, and may remain convertible thereafter if specific conditions in the Indenture are met during future measurement periods. Wells Fargo Bank, National Association serves as the trustee and conversion agent. No specific forward-looking guidance on revenue or earnings is provided in this filing.
Key Facts for Investor Verification
- Verify the current trading price of OPKO Health common stock relative to the $9.19 threshold to assess the likelihood of continued convertibility.
- Confirm the total principal amount of outstanding Notes ($32.2 million) and potential dilution impact if converted.
- Review the Indenture dated January 30, 2013, for details on early conversion provisions and additional share calculations.
- Monitor future filings to determine if the conversion right is extended beyond September 30, 2016.